 |
Overview| President Junichi Hamada | Director Kazunori Kataoka |
- 2011. 2. 10
Polymeric micelles as nano-scaled Trojan Horse was highlighted in the web site of Nature Japan for the successful chemothrapy to treat drug-resistant tumors.
(Details)
- 2011. 1. 28
Targeting therapy to treat drug-resistant tumor by polymeric micelles were carried in Nikkei Sangyo Shimbun. (Details)
- 2011. 1. 6
Our paper entitled "Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting" was selected as a cover of Sci. Transl. Med.(Vol.3, No.64, January 2011) (The pdf file is available from here) and the research of the paper was carried in Nippon Keizai Newspaper, Mainichi Newspaper, Yomiuri Newspaper, NHK News etc. (Details)
- September 9, 2010: Parliamentary Secretary of Cabinet Office for Economic and Fiscal Policy, Science and Technology Policy, and Promotion of Local Sovereignty, Keisuke Tsumura visited Center for Nanobio Integration and Nanobio First project in the Tokyo University. After projects were reviewed by Professor Kataoka and Mr. Tsumura visited research facilities and communicated with researchers.
- September 2, 2010: Dr. Cristina Garmendia, the Minister of Science
Innovation, Spain, and her delegates visited CNBI to inspect our FIRST
project on nanobiotechnolgy and drug delivery.
- GCOE Medical Innovation Seminar
March 6, 2012
Dawn and Development of Channelopathy:How I Develop My Scientific Careers, D.V.D., Ph.D., Toshio Narahashi(John Evans Professor of Pharmacology Northwestern University Feinberg School of Medicine, USA)
PDF
Registration
Mechanism of Neurotoxic Action of Insecticides, Prof. Toshio Narahashi(Northwestern University Feinberg School of Medicine, USA)
PDF
Registration
March 2, 2012
Associate Prof., Atsushi Takeda(Department of Medical Biochemistry, University of Shizuoka )
PDF
Registration
February 29, 2012
Artificial Protein Biomaterials for Tissue Regeneration and Repair, Dr. Eileen Fong(School of Materials Science and Engineering, Nanyang Technological University, Singapore)
PDF
Registration
February 28, 2012
Science English, Vice President Academic Programs,
Professor, Oliver Bogler(Neurosurgery,
The University of Texas M.D. Anderson Cancer Center, U.S.A.)
PDF
Registration
February 21, 2012
Recent Advances in Bromination Reactions, Dr. Yeung Yin Yeung(National University of Singapore, Singapore)
PDF
Registration
Prof. Hideyuki Saya(Division of Gene Regulation, Institute for Advanced Medical Research, School of Medicine, Keio University)
PDF
Registration
February 13, 2012
Humanized Transgenic Mouse Models for PK, Drug-Drug Interaction and Safety Testing of Compounds, Mr. Nico Scheer(TaconicArtemis GmbH, Cologne, Germany)
PDF
Registration
February 10, 2012
Poly(2-oxazoline)s: From a Potential Alternative for the "Gold Standard" Poly(ethylene oxide) to Tailor-Made Linear Poly(ethylene imine)s, Prof. Ulrich S. Schubert(Friedrich-Schiller-University Jena, Germany)
PDF
Registration
February 7, 2012
Dr., Kunio Torii(AJINOMOTO)
PDF
Registration
- Symposium Cooperated by CNBI
March 15-18, 2011
International Conference on Biomaterials Science 2011 (ICBS2011)
Overview
- Now you can download the CNBI newsletter. ( * English version only)
Please register here for membership. Membership allows you to download the newsletter.
|
-
90th GCOE Medical Innovation Seminar (January 24, 2012)
Prof., Akihiko Konagaya(Department of Computational Intelligence and System Science, Interdisciplinary Graduate School of Science and Engineering, Tokyo Institute of Technology)
PDF
-
89th GCOE Medical Innovation Seminar (January 23, 2012)
The Role of Applied Research for Innovation and Entrepreneurship Lessons learned from SRI International, Steve J. Ciesinski(Graduate School of Business, Stanford University,
Vice President of Strategic Business Development,
SRI International, USA)
PDF
-
88th GCOE Medical Innovation Seminar (January 17, 2012)
Takafumi Sakai, Professor(Graduate School of Science and Engineering, Saitama University)
PDF
-
87th GCOE Medical Innovation Seminar (December 20, 2011)
Structure and Behavior of Four-helix Bundle Cavitein Systems, Dr. Jon Oliver Freeman(University of British Columbia, CANADA)
PDF
-
86th GCOE Medical Innovation Seminar (December 20, 2011)
Total Synthesis and Drug Pursuits: Laetirobins, Lipstatins, Platensimycins, Dr. Martin James Lear(National University of Singapore, Singapore)
PDF
-
85th GCOE Medical Innovation Seminar (December 7, 2011)
Prof., Eisaku Kondo (Graduate School of Medicine, Nagoya University)
PDF
-
84th GCOE Medical Innovation Seminar (December 5, 2011)
Directing Cellular Traffic Using Geometric and Biomolecular Cues,
Prof., Keiichiro Kushiro ( Department of Chemical engineering, Northeasten University, USA)
PDF
-
83th GCOE Medical Innovation Seminar (November 15, 2011)
ALDEHYDE OXIDASE IN DRUG RESEARCH, Dr. R. Scott Obach(Dept. of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism Pfizer Global Research and Development, Groton Laboratories, USA)
PDF
-
82th GCOE Medical Innovation Seminar (November 8, 2011)
Prof., Junji Watanabe(Department of Organic and Polymeric Materials, Tokyo Institute of Technology)
PDF
-
81th GCOE Medical Innovation Seminar (October 19, 2011)
The Surprising Mechanism of Utilization of the AH Receptor by Breast Cancer Cells for Their Survival Advantages
, Prof. Fumio Matsumura(Department of Environmental Toxicology and Department of Entomology, University of California Davis, USA)
PDF
|
 |
-
Excellent Paper Award 2011
was given by The Society for Biotechnology, Japan
.
(Professor Jun Miyake, Graduate School of Engineering)
-
Uehara Award
was given by The Uehara Memorial Foundation
.
(Professor Haruo Kasai, Graduate School of Medicine)
-
Targeting therapy of cancer by polymeric micelles was carried in Yomiuri Shimbun.
(Prof. Kazunori Kataoka, Graduate School of Engineering, Graduate School of Medicine)
-
Medal with Purple Ribbon
was given by Cabinet Office
.
(Professor Takuzo Aida, Graduate School of Engineering)
-
Research activity on drug delivery system was carried in September 2010 issue of "Highlighting Japan" published by the Japanese Government. (Prof. Kazunori Kataoka, Graduate School of Engineering, Graduate School of Medicine)
-
Development of visible drug delivery system for the diagnosis and therapy of pancreatic tumors was carried in Mainichi Newspaper, Nikkei Sangyo Newspaper and Nippon Keizai Newspaper (Web) (Professor Kazunori Kataoka, Graduate Schools of Engineering and Medicine, The University of Tokyo, Professor Toru Tani, Department of Surgery, Shiga University of Medical Science, and Dr. Ichio Aoki, Molecular Imaging Center, National Institute of Radiological Sciences)
|
President of The University of Tokyo
Junichi Hamada |
The world today is facing a period of dramatic changes. As industry and economy are suffering great instability on a global scale and the foundations of individuals’ livelihoods are being eroded, society is searching for a reliable compass to the future. Academia is expected to sketch the outline of this future society and mark the path to reach that goal. The University of Tokyo is committed to fulfilling its public responsibility through academic research and fostering of new talent, thus providing a reliable compass to the future. To fulfill this purpose, we will focus not just on scholarship for acclaim today, but also ensure the sustenance, continued development and integration of diverse disciplines so that we can enrich the foundations of knowledge and nurture new sources of creativity.
In the medical field, although systematic molecular-level investigations into the cause of diseases are proceeding at a rapid rate, individual basic academic knowledge does not effectively lead to treatment of diseases. To solve this problem, it is necessary to conduct both basic academic research and innovative and integrative approaches. The University of Tokyo Center for NanoBio Integration will be a pioneering research center that integrates knowledge dispersed among different disciplines including biosensing technology, biomaterial technology, molecular simulation technology and nanoscale-biotechnology toward the medical applications.
I believe that through the creation of knowledge, through education and through close association with society, now more than ever is the time in which the University of Tokyo must fulfill its public responsibility towards the future of Japan and of the world community. As a “Global Cornerstone of Human Knowledge”, the University of Tokyo, with its abundant conceptual powers, is determined to forge ahead on the pathway to that future.
|
|
Center Director
Kazunori Kataoka
|
In recent years, in science and engineering fields, assembly technology
on a microscale or even nanoscale has made great strides. Not only in semiconductor
technology, but also in mechanical engineering, micro/nanomachining technology
based on micro/nano manufacturing and micro/nano assembly has been increasingly
sophisticated, making steady progress toward high-performance and high-precision.
On the other hand, in materials science and materials engineering, in addition
to traditional design methods based on macroproperty, materials design
based on nanoassembly that manipulates molecules and atoms has appeared,
making a high impact on highly advanced functional materials area. The
progresses in hardware including assembly, micronization and intellectualization
are helping integrate materials science, materials engineering, electronic
engineering and mechanical engineering that have been separately evolving
based on the unique concepts. In other words, advances are helping integrate
the bottom-up method of atomic or molecular assembly and top-down method
of nano/microscopic manufacturing."Nano integration" is defined
as the integration of sophisticated systems into materials on a nanoscale.
On reflection, such"nano integration" can be seen in a large
number of our body structures that govern complicated functions, suggesting
that"nano integration" is a process suitable for biological evolution.
In this sense, to further the development of sophisticated device systems
based on"nano integration", it is important to promote research
and development on"nanobio integration", including the understanding
of structures and functions of the body on a nanoscale, the creation of
structures and functions inspired by the operational principles of the
body and the establishment of the methodology that regulates the functions
of body components including biomolecules and cells and integrates them
into devices.
"Nanobio integration", a concept covering traditional science
and technology fields, is expected to develop in broad areas of industries,
especially life science and biotechnology fields. Throughout the 20th century,
life science and biotechnology have made tremendous progress and have contributed
to building a safe and secure society through overcoming a number of intractable
diseases and enhancing food and environmental safety. Moreover, in the
21st century, based on the integration of vast amounts of knowledge from
molecular biology and cellular biology, rapid progress has been made in
innovative medical technologies represented by gene diagnosis and therapy
and tissue engineering. Environmental assessment techniques and alternative
techniques for animal experiments which integrate the body system including
proteins and cells have been developed. Even biosynthesis and bioprocessing
technologies, inspired by smart body structures and functions, have been
created. In the 20th century, the primary focus was placed on"research
on the biological system at molecular and cellular levels." In the
21st century, an additional focus has been placed on utilization of the
biological system at molecular and cellular levels.
Promoting nanodevice system research which highly integrates the above-mentioned life science and biotechnology, the Center for NanoBio Integration aims to create the interdisciplinary scientific technological system and intellectual basis that explore and reveal the nature of the biological functions on a nanoscale and to promote the construction of an innovative"nanomedical" system based on nanoscale spatiotemporal bioregulation and the establishment of new bioindustries that open up the future for our country. All of our members work hard and enthusiastically to produce and disseminate innovative research results"that may astonish the world". Your advice and support are greatly appreciated.
|
|
|
 |
Last Updated:
|
 |